Laman UtamaEUFA3 • BVMF
add
Eurofarma Laboratorios SA
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (BRL) | Sep 2025info | Perubahan T/T |
|---|---|---|
Hasil | 3.21B | 14.03% |
Perbelanjaan pengendalian | 1.41B | -8.77% |
Pendapatan bersih | 357.84J | 165.02% |
Margin untung bersih | 11.15 | 132.29% |
Pendapatan bagi setiap syer | — | — |
EBITDA | 825.36J | 89.77% |
Kadar cukai berkesan | 10.45% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (BRL) | Sep 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 1.29B | -40.20% |
Jumlah aset | 17.83B | 3.99% |
Jumlah liabiliti | 12.90B | 3.31% |
Jumlah ekuiti | 4.93B | — |
Syer tertunggak | 989.21J | — |
Harga kepada buku | — | — |
Pulangan pada aset | 10.11% | — |
Pulangan pada modal | 12.00% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (BRL) | Sep 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 357.84J | 165.02% |
Tunai daripada operasi | 502.28J | -4.09% |
Tunai daripada pelaburan | -127.54J | 62.89% |
Tunai daripada pembiayaan | -576.73J | -404.59% |
Perubahan bersih dalam tunai | -212.73J | -163.15% |
Aliran tunai bebas | -231.08J | -15.34% |
Perihal
Eurofarma is a Brazilian multinational corporation engaged in biopharmaceutical manufacturing and is one of the largest medicine producers in Brazil and Latin America. Founded in 1972, Eurofarma offers generic, oncologic and veterinary medications. Within Brazil the company is responsible for about 2000 products, representing 66% of the total market.
Eurofarma has active operations in 20 countries, with factories in Brazil, Argentina, Bolivia, Chile, Colombia, Ecuador, Guatemala, Mexico, Mozambique, Paraguay, Peru, Uruguay and Venezuela. Wikipedia
Diasaskan
1972
Tapak web
Pekerja
13,000
